• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五例埃博拉病毒感染者的止血变化。

Haemostatic Changes in Five Patients Infected with Ebola Virus.

机构信息

Chemical Biological & Radiological Division, Dstl, Porton Down SP4 0JQ, UK.

Royal Centre for Defence Medicine, Birmingham Research Park, Birmingham B15 2SQ, UK.

出版信息

Viruses. 2019 Jul 15;11(7):647. doi: 10.3390/v11070647.

DOI:10.3390/v11070647
PMID:31311112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6669445/
Abstract

Knowledge on haemostatic changes in humans infected with Ebola virus is limited due to safety concerns and access to patient samples. Ethical approval was obtained to collect plasma samples from patients in Sierra Leone infected with Ebola virus over time and samples were analysed for clotting time, fibrinogen, and D-dimer levels. Plasma from healthy volunteers was also collected by two methods to determine effect of centrifugation on test results as blood collected in Sierra Leone was not centrifuged. Collecting plasma without centrifugation only affected D-dimer values. Patients with Ebola virus disease had higher PT and APTT and D-dimer values than healthy humans with plasma collected in the same manner. Fibrinogen levels in patients with Ebola virus disease were normal or lower than values measured in healthy people. Clotting times and D-dimer levels were elevated during infection with Ebola virus but return to normal over time in patients that survived and therefore could be considered prognostic. Informative data can be obtained from plasma collected without centrifugation which could improve patient monitoring in hazardous environments.

摘要

由于安全问题和获取患者样本的限制,人们对感染埃博拉病毒的人类的止血变化知之甚少。获得了从塞拉利昂感染埃博拉病毒的患者身上随时间采集血浆样本的伦理批准,并分析了凝血时间、纤维蛋白原和 D-二聚体水平。还通过两种方法从健康志愿者身上采集血浆,以确定离心对测试结果的影响,因为在塞拉利昂采集的血液未离心。不离心采集血浆仅会影响 D-二聚体值。与以相同方式采集血浆的健康人类相比,埃博拉病毒病患者的 PT 和 APTT 以及 D-二聚体值更高。埃博拉病毒病患者的纤维蛋白原水平正常或低于健康人群的测量值。在感染埃博拉病毒期间,凝血时间和 D-二聚体水平升高,但在存活的患者中随着时间的推移恢复正常,因此可以被认为具有预后价值。可以从无需离心的血浆中获得有价值的数据,这可以改善危险环境中患者的监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d175/6669445/b6a073e2574d/viruses-11-00647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d175/6669445/a707858307cc/viruses-11-00647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d175/6669445/b6a073e2574d/viruses-11-00647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d175/6669445/a707858307cc/viruses-11-00647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d175/6669445/b6a073e2574d/viruses-11-00647-g002.jpg

相似文献

1
Haemostatic Changes in Five Patients Infected with Ebola Virus.五例埃博拉病毒感染者的止血变化。
Viruses. 2019 Jul 15;11(7):647. doi: 10.3390/v11070647.
2
Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study.GeneXpert埃博拉检测法在塞拉利昂诊断埃博拉病毒病中的性能:一项现场评估研究。
PLoS Med. 2016 Mar 29;13(3):e1001980. doi: 10.1371/journal.pmed.1001980. eCollection 2016 Mar.
3
Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus.感染苏丹埃博拉病毒的人类中与致命和非致命结局相关的血液化学测量值及D - 二聚体水平。
J Infect Dis. 2007 Nov 15;196 Suppl 2:S364-71. doi: 10.1086/520613.
4
Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study.塞拉利昂埃博拉病毒病的死亡、晚期死亡及感染剂量的作用:一项回顾性队列研究
BMJ. 2016 May 17;353:i2403. doi: 10.1136/bmj.i2403.
5
Notes from The Field: Ebola Virus Disease Cluster - Northern Sierra Leone, January 2016.现场记录:埃博拉病毒病疫情聚集 - 2016 年 1 月,塞拉利昂北方省。
MMWR Morb Mortal Wkly Rep. 2016 Jul 8;65(26):681-2. doi: 10.15585/mmwr.mm6526a4.
6
Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone.埃博拉病毒病合并迟发性脑炎和多关节炎,塞拉利昂
Emerg Infect Dis. 2016 Jan;22(1):150-2. doi: 10.3201/eid2201.151212.
7
Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study.塞拉利昂埃博拉病毒病幸存者中的病毒血症和埃博拉病毒分泌:一项横断面队列研究。
Lancet Infect Dis. 2016 Sep;16(9):1052-1056. doi: 10.1016/S1473-3099(16)30060-3. Epub 2016 May 17.
8
Serological Investigation of Laboratory-Confirmed and Suspected Ebola Virus Disease Patients During the Late Phase of the Ebola Outbreak in Sierra Leone.塞拉利昂埃博拉疫情后期实验室确诊和疑似埃博拉病毒病患者的血清学调查。
Virol Sin. 2018 Aug;33(4):323-334. doi: 10.1007/s12250-018-0044-z. Epub 2018 Jul 31.
9
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.在塞拉利昂健康成年人中使用重组腺病毒 5 型载体埃博拉疫苗的安全性和免疫原性:一项单中心、随机、双盲、安慰剂对照、2 期临床试验。
Lancet. 2017 Feb 11;389(10069):621-628. doi: 10.1016/S0140-6736(16)32617-4. Epub 2016 Dec 23.
10
Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.塞拉利昂埃博拉病毒幸存者及其密切接触者的血清学分析:一项横断面研究。
PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007654. doi: 10.1371/journal.pntd.0007654. eCollection 2019 Aug.

引用本文的文献

1
Viral Disruption of Blood-Testis Barrier Precedes Testicular Infection.血睾屏障的病毒破坏先于睾丸感染。
Viruses. 2025 May 23;17(6):747. doi: 10.3390/v17060747.
2
Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study.黎巴嫩新冠肺炎患者血栓形成的几率及相关因素:一项病例对照回顾性研究。
J Pharm Policy Pract. 2024 Mar 14;17(1):2319743. doi: 10.1080/20523211.2024.2319743. eCollection 2024.
3
Association of d-dimer levels with in-hospital outcomes among COVID-19 positive patients: a developing country multicenter retrospective cohort.

本文引用的文献

1
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study.埃博拉患者病毒血症与特定器官损伤的关系:一项队列研究。
Clin Infect Dis. 2018 Jan 6;66(1):36-44. doi: 10.1093/cid/cix704.
2
Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness.为非人类灵长类动物提供长期强化护理:危重病的高保真动物模型。
Sci Rep. 2017 Apr 26;7(1):1204. doi: 10.1038/s41598-017-01107-6.
3
Disseminated Intravascular Coagulation.弥散性血管内凝血
新冠病毒阳性患者的D-二聚体水平与院内结局的关联:一个发展中国家的多中心回顾性队列研究
Ann Med Surg (Lond). 2023 Apr 13;85(5):1527-1533. doi: 10.1097/MS9.0000000000000633. eCollection 2023 May.
4
Ebola virus infection induces a delayed type I IFN response in bystander cells and the shutdown of key liver genes in human iPSC-derived hepatocytes.埃博拉病毒感染可诱导旁观者细胞产生延迟的 I 型干扰素反应,并导致人诱导多能干细胞来源的肝细胞中关键肝脏基因失活。
Stem Cell Reports. 2022 Oct 11;17(10):2286-2302. doi: 10.1016/j.stemcr.2022.08.003. Epub 2022 Sep 8.
5
Hyperinflammation, apoptosis, and organ damage.过度炎症、细胞凋亡和器官损伤。
Exp Biol Med (Maywood). 2022 Jul;247(13):1112-1123. doi: 10.1177/15353702221090454. Epub 2022 Apr 27.
6
Clinical Features and Management of COVID-19-Associated Hypercoagulability.新型冠状病毒病相关高凝血症的临床特征和处理。
Card Electrophysiol Clin. 2022 Mar;14(1):41-52. doi: 10.1016/j.ccep.2021.10.005. Epub 2021 Oct 30.
7
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19.是否与内皮功能障碍和血栓形成有关?COVID-19 的秘密。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211042940. doi: 10.1177/10760296211042940.
8
Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.病毒诱导的炎症性凝血障碍:为另一场疫情做准备。
Thromb Haemost. 2022 Jan;122(1):8-19. doi: 10.1055/a-1562-7599. Epub 2021 Sep 13.
9
Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.新型冠状病毒肺炎的血栓栓塞并发症与代谢紊乱:基于临床实践证据对病因的探讨
Metabolites. 2021 May 25;11(6):341. doi: 10.3390/metabo11060341.
10
Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus.埃博拉病毒感染培养的人肝细胞中微小 RNA 转录组的改变。
Int J Mol Sci. 2021 Apr 6;22(7):3792. doi: 10.3390/ijms22073792.
Am J Clin Pathol. 2016 Dec;146(6):670-680. doi: 10.1093/ajcp/aqw195. Epub 2016 Dec 24.
4
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.止血实验室的分析前问题:临床实验室指南
Thromb J. 2016 Dec 12;14:49. doi: 10.1186/s12959-016-0123-z. eCollection 2016.
5
How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.埃博拉病毒和马尔堡病毒的严重程度及流行情况如何?病死率和血清阳性率的系统评价与荟萃分析。
BMC Infect Dis. 2016 Nov 25;16(1):708. doi: 10.1186/s12879-016-2045-6.
6
Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome.离心作用重要吗?离心力和旋转时间会改变血浆代谢组。
Metabolomics. 2016;12(10):159. doi: 10.1007/s11306-016-1109-3. Epub 2016 Sep 15.
7
Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.美国埃博拉病毒病患者队列中生物标志物的动力学分析。
Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27.
8
Prognostic Indicators for Ebola Patient Survival.埃博拉患者生存的预后指标
Emerg Infect Dis. 2016 Feb;22(2):217-23. doi: 10.3201/eid2202.151250.
9
Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease.血栓弹力描记术在埃博拉病毒病相关凝血功能障碍管理中的应用。
Clin Infect Dis. 2016 Mar 1;62(5):610-612. doi: 10.1093/cid/civ977. Epub 2015 Nov 26.
10
Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.埃博拉病毒病患者的临床表现、生化和血液学参数及其与预后的关系:一项观察性队列研究。
Lancet Infect Dis. 2015 Nov;15(11):1292-9. doi: 10.1016/S1473-3099(15)00144-9. Epub 2015 Aug 10.